Compound information
- Natural Products
- ZC742858
- Molecular Formula
- C23H34N4O6S
- Molecular Weight
- 494.219905808 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-[4-[4-(benzenesulfonyl)piperazin-1-yl]-4-oxo-butanoyl]piperazine-1-carboxylate
- InChI
- InChI=1S/C23H34N4O6S/c1-23(2,3)33-22(30)26-13-11-24(12-14-26)20(28)9-10-21(29)25-15-17-27(18-16-25)34(31,32)19-7-5-4-6-8-19/h4-8H,9-18H2,1-3H3
- InChI Key
- ZHCJGRDRWWJZLR-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(C(=O)CCC(=O)N2CCN(S(=O)(=O)c3ccccc3)CC2)CC1
- Source
- ZINC000023458434
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 3 |
Heteroatom Count | 11 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 107.54 Å2 | LogP | 1.018 |
LogS | -2.586 | LogD | 1.712 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.732 | Pgp substrate | 1.0 |
HIA | 0.835 | F20 % | 0.112 |
F30 % | 0.06 | Caco-2 | -5.133 |
MDCK | -4.983 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.169 | PPB | 57.992 |
VD | 0.904 | Fu | 0.565 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.332 |
CYP2A6 substrate | 0.293 | CYP2B6 substrate | 0.511 |
CYP2C19 inhibitor | 0.37 | CYP2C19 substrate | 0.491 |
CYP2C8 substrate | 0.517 | CYP2C9 inhibitor | 0.136 |
CYP2C9 substrate | 0.675 | CYP2D6 inhibitor | 0.042 |
CYP2D6 substrate | 0.185 | CYP2E1 substrate | 0.305 |
CYP3A4 inhibitor | 0.307 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.787 | CL | 2.705 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.018 | Hepatotoxicity | 0.987 |
Mutagenicity | 0.841 | Rat Oral Acute Toxicity | 0.898 |
FDAMDD | 0.661 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.044 | Eye Corrosion | 0.002 |
Eye Irritation | 0.003 | Respiratory Toxicity | 0.012 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.336 | IGC50 | 2.327 |
LC50FM | -14.385 | LC50DM | -3.573 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.366 | NR-AR-LBD | 0.359 |
NR-AhR | 0.043 | NR-Aromatase | 0.01 |
NR-ER | 0.236 | NR-ER-LBD | 0.366 |
NR-PPAR-gamma | 0.061 | SR-ARE | 0.576 |
SR-ATAD5 | 0.331 | SR-HSE | 0.078 |
SR-MMP | 0.009 | SR-p53 | 0.058 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.